Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan added to usual care for arterial stiffness in systemic sclerosis with digital ulcers
2014-002796-28Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Apr 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bosentan in systemic sclerosis (SSc) (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Mean of right and left carotid-femoral arterial pulse wave velocity. Started Apr 2015; status: active.
02
Drugs
bosentan
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on 2014-002796-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002796-28.